StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.34−0.64 (-3.37%)

Close on Nov 19, 2026Market cap $881.39MP/E –Yield –

Odyssey Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$55.47M–
Q1 FY2026Mar 31, 2026-$39.78M–
Q2 FY2025Jun 30, 2025-$41.92M–
Q1 FY2025Mar 31, 2025-$39.16M–

More Odyssey Therapeutics figures

See a number that looks wrong?